CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the Unstoppable Stocks to Buy and Hold for the Next 5 Years. On September 23, analyst Mitchell Kapoor from H.C. Wainwright reiterated a “Buy” rating on ...

Clinical evidence from studies on atrial fibrillation (AF) and total knee arthroplasty (TKA) indicates that FXI is an appealing target that may upend the $15 billion thromboembolism market, which is ...

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $51.81, marking a -3.5% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.3% for the ...

The Vanguard Total Stock Market Index Fund ETF is a classic pick for savvy long-term investors. That's because the ETF tracks ...

CRISPR stock is a bold investment in the future. Beyond the valuation, thematically and based on current market dynamics, I consider this a venture-style winner. Just because CRISPR stock may be a ...

On July 30, 2025, Morningstar, Inc. (NASDAQ:MORN) reported its Q2 2025 financial results, highlighting a revenue increase of ...

Morningstar, a Chicago-based financial services firm, has announced plans to acquire the Center for Research in Security ...

As part of the transaction, Morningstar will acquire the CRSP Market Indexes, which are the benchmarks for more than $3 trillion in US equities across market capitalizations, investment styles, and ...